Advanced design and viral production services enable you to move forward toward your next discovery. From design, synthesis, and production of viral particles, we offer end-to-end services to support every step in your lentivirus (LV) and Adeno-associated virus (AAV) RUO production. Our dedicated staff of R&D scientists and project managers are ready to partner with you and your colleagues to help accelerate your research program. If you’re looking for larger-scale production or seeking CDMO guidance on virus production.
Titer determined by p24 ELISA for Lentivirus or qPCR for AAV
Optional functional titer of viral particles available as a separate assay
Final deliverable: concentrated virus particles, 1 mL (5 x 200 µL) with an average titer range between 106–109 for lentivirus and 109–1012 for AAV
Viral production depends on advanced technologies
The Gibco Lentiviral Production systems are the first optimized systems that provide all the high-quality components you need in a chemically defined, serum-free environment.
Gibco AAV Max Helper-Free AAV Production System Kit
AAV-MAX is a scalable, high-titer platform for suspension AAV production that can help enable you to seamlessly transition from discovery to commercial production.
LV-MAX is designed to seamlessly transition from discovery to commercial production, offering a scalable and high-yield lentiviral production platform. It is a suspension based, high-density culture of HEK 293–derived Viral Production Cells adapted to a special chemically defined, serum-free and protein-free LV-MAX Production Medium.